{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:51:26Z","timestamp":1790898686716,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Biological Regulation"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jbior.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T21:17:09Z","timestamp":1494278229000},"page":"26-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["GSK-3 as a novel prognostic indicator in leukemia"],"prefix":"10.1016","volume":"65","author":[{"given":"Peter P.","family":"Ruvolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbior.2017.05.001_bib1","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"beta-catenin is a target for the ubiquitin-proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.jbior.2017.05.001_bib2","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1073\/pnas.0900189106","article-title":"Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation","volume":"106","author":"Abrahamsson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2017.05.001_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI46465","article-title":"The intersection of genetic and chemical genomic screens identifies GSK-3\u03b1 as a target in human acute myeloid leukemia","volume":"122","author":"Banerji","year":"2012","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jbior.2017.05.001_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jbior.2015.05.001","article-title":"Implication of PI3K\/Akt pathway in pancreatic cancer: when PI3K isoforms matter?","volume":"59","author":"Baer","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib5","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/onc.2009.179","article-title":"The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKC delta and proteasome-dependent regulation of Mcl-1 expression","volume":"28","author":"Baudot","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2017.05.001_bib6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jbior.2017.05.001_bib7","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1158\/1078-0432.CCR-13-2491","article-title":"Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells","volume":"20","author":"Benoit","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbior.2017.05.001_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2013.09.018","article-title":"Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells","volume":"382","author":"Biver","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jbior.2017.05.001_bib9","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/jcb.25231","article-title":"EGF inhibits Wnt\/\u03b2-catenin-induced osteoblast differentiation by promoting \u03b2-catenin degradation","volume":"116","author":"Boonanantanasarn","year":"2015","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.jbior.2017.05.001_bib10","first-page":"12","article-title":"Mcl-1 as a therapeutic target in acute myelogenous leukemia (AML)","volume":"2","author":"Bose","year":"2013","journal-title":"Leuk. Res. Rep."},{"key":"10.1016\/j.jbior.2017.05.001_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jcp.21848","article-title":"PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation","volume":"221","author":"Blalock","year":"2009","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.jbior.2017.05.001_bib13","first-page":"21","article-title":"The complexity of targeting PI3K-Akt-mTOR signalling in human acute myeloid leukaemia: the importance of leukemic cell heterogeneity, neighbouring mesenchymal stem cells and immunocompetent cells","author":"Brenner","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jbior.2017.05.001_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2006-10-050260","article-title":"Targeting autophagy\u00a0augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance","volume":"110","author":"Carew","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2003.04452.x","article-title":"Phosphatase and tensin homologue phosphorylation in the C-terminal\u00a0regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome","volume":"122","author":"Cheong","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jbior.2017.05.001_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jbior.2014.07.002","article-title":"PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting","volume":"56","author":"Ciuffreda","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s12015-013-9436-5","article-title":"Wnt signaling behaves as a \"master regulator\" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells","volume":"9","author":"D'Alimonte","year":"2013","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.jbior.2017.05.001_bib18","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1182\/blood-2004-07-2767","article-title":"Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK\/ERK pathways and activation of SEK1\/JNK","volume":"105","author":"Dai","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib19","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2014-10-605808","article-title":"Secondary mutations as mediators of resistance to targeted therapy in leukemia","volume":"125","author":"Daver","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib20","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.18632\/oncotarget.2209","article-title":"Deregulation of the EGFR\/PI3K\/PTEN\/Akt\/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention","volume":"5","author":"Davis","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2017.05.001_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1634\/stemcells.20-3-205","article-title":"Origin and differentiation of human and murine stroma","volume":"20","author":"Dennis","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbior.2017.05.001_bib22","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1209346","article-title":"A\u00a0crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia","volume":"25","author":"De Toni","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2017.05.001_bib23","doi-asserted-by":"crossref","first-page":"e9807","DOI":"10.1371\/journal.pone.0009807","article-title":"A\u00a0New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells","volume":"5","author":"De Toni-Costes","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbior.2017.05.001_bib24","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","article-title":"Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization","volume":"12","author":"Diehl","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbior.2017.05.001_bib26","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1038\/cddis.2012.111","article-title":"Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence","volume":"3","author":"Drullion","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbior.2017.05.001_bib27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1182\/blood-2014-05-574830","article-title":"PKC-\u03b2 as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL","volume":"124","author":"El-Gamal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1124\/mol.108.047639","article-title":"Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia","volume":"74","author":"Fala","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbior.2017.05.001_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jbior.2015.06.003","article-title":"Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells","volume":"59","author":"Fitzgerald","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jbior.2014.10.004","article-title":"PLC and PI3K\/Akt\/mTOR signalling in disease and cancer","volume":"57","author":"Follo","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jbior.2014.05.005","article-title":"PTEN and leukemia stem cells","volume":"56","author":"Fragoso","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2007.09.027","article-title":"Integrating patterning signals: Wnt\/GSK3 regulates the duration of the BMP\/Smad1 signal","volume":"131","author":"Fuentealba","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib33","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2009-09-242719","article-title":"Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression","volume":"115","author":"Ghosh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00062752-200207000-00003","article-title":"Role of FLT3 in leukemia","volume":"9","author":"Gilliland","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.jbior.2017.05.001_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbior.2017.05.001_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/j.seminhematol.2015.03.004","article-title":"FLT3 tyrosine kinase inhibition as a paradigm for targeted drug development in acute myeloid leukemia","volume":"52","author":"Grunwald","year":"2015","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.jbior.2017.05.001_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ccell.2015.11.012","article-title":"GSK3 deficiencies in hematopoietic stem cells initiate pre-neoplastic state that is predictive of clinical outcomes of human acute leukemia","volume":"29","author":"Guezguez","year":"2016","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jbior.2017.05.001_bib38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/leu.2012.2","article-title":"GSK3 is a regulator of RAR-mediated differentiation","volume":"26","author":"Gupta","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2017.05.001_bib39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0092-8674(01)00412-3","article-title":"Regulation of GSK-3: a cellular multiprocessor","volume":"105","author":"Harwood","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0165-6147(99)01369-3","article-title":"Emerging roles for RGS proteins in cell signalling","volume":"20","author":"Hepler","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbior.2017.05.001_bib41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/1535-7163.MCT-10-0904","article-title":"The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3\u03b2-dependent pathway","volume":"10","author":"Hernandez-Davies","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbior.2017.05.001_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pathol-012615-044414","article-title":"Hematopoietic stem cell niche in health and disease","volume":"11","author":"Hoggatt","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jbior.2017.05.001_bib43","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2174\/092986708784638834","article-title":"The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia","volume":"15","author":"Holmes","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jbior.2017.05.001_bib44","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1158\/1535-7163.MCT-15-0566","article-title":"A\u00a0novel glycogen synthase Kinase-3 inhibitor optimized for acute myeloid leukemia differentiation activity","volume":"15","author":"Hu","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbior.2017.05.001_bib45","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1124\/jpet.108.148122","article-title":"Glycogen synthase kinase-3beta mediates endoplasmic reticulum stress-induced lysosomal apoptosis in leukemia","volume":"329","author":"Huang","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbior.2017.05.001_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature09732","article-title":"SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction","volume":"471","author":"Inuzuka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2017.05.001_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.18632\/oncotarget.242","article-title":"Mcl-1 ubiquitination and destruction","volume":"2","author":"Inuzuka","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2017.05.001_bib48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1073\/pnas.1213021110","article-title":"ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia","volume":"110","author":"Jiang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2017.05.001_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jbior.2014.09.004","article-title":"Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes","volume":"57","author":"Jhanwar-Uniyal","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib50","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood.V91.3.991","article-title":"Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse","volume":"91","author":"Kaufmann","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib51","doi-asserted-by":"crossref","first-page":"e54122","DOI":"10.1371\/journal.pone.0054122","article-title":"Protein kinase C regulates human pluripotent stem cell self-renewal","volume":"8","author":"Kinehara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbior.2017.05.001_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature12883","article-title":"Leukaemogenesis induced by an activating \u03b2-catenin mutation in osteoblasts","volume":"506","author":"Kode","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2017.05.001_bib53","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/leu.2011.287","article-title":"MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1\/BIM complex","volume":"26","author":"Konopleva","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2017.05.001_bib54","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1078-0432.CCR-13-1978","article-title":"Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia","volume":"20","author":"Konopleva","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbior.2017.05.001_bib55","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2006-02-003475","article-title":"Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia","volume":"108","author":"Kornblau","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib56","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.4161\/cc.5.23.3507","article-title":"Studying the right cell in acute myelogenous leukemia: dynamic changes of apoptosis and signal transduction pathway protein expression in chemotherapy resistant ex-vivo selected \"survivor cells\"","volume":"5","author":"Kornblau","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2017.05.001_bib57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2407-14-71","article-title":"The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells","volume":"14","author":"Kretzschmar","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbior.2017.05.001_bib58","doi-asserted-by":"crossref","first-page":"30975","DOI":"10.1074\/jbc.M115.669531","article-title":"E3 ubiquitin ligase Fbw7 negatively regulates osteoblast differentiation by targeting Runx2 for degradation","volume":"290","author":"Kumar","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbior.2017.05.001_bib59","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.20691","article-title":"GSK3B polymorphisms alter transcription and splicing in Parkinson's disease","volume":"58","author":"Kwok","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbior.2017.05.001_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(00)00039-3","article-title":"The protooncogene TCL1 is an Akt kinase coactivator","volume":"6","author":"Laine","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib61","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2006.03.005","article-title":"Growth factor withdrawal and apoptosis: the middle game","volume":"21","author":"Letai","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jad.2012.08.025","article-title":"Glycogen synthase kinase 3\u03b2 gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium","volume":"147","author":"Lin","year":"2013","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jbior.2017.05.001_bib63","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1007\/s13277-015-4510-z","article-title":"Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jbior.2017.05.001_bib64","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.bbamcr.2013.06.018","article-title":"E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation","volume":"1833","author":"Lochab","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbior.2017.05.001_bib65","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/j.1538-7836.2012.04903.x","article-title":"Regulators of G protein signaling: role in hematopoiesis, megakaryopoiesis and platelet function","volume":"10","author":"Louwette","year":"2012","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.jbior.2017.05.001_bib66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbagrm.2013.09.005","article-title":"Transcription regulation and chromatin structure in the pluripotent ground state","volume":"1839","author":"Marks","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbior.2017.05.001_bib67","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/leu.2013.184","article-title":"Multifaceted roles of GSK-3 and Wnt\/\u03b2-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention","volume":"28","author":"McCubrey","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2017.05.001_bib69","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.18632\/oncotarget.2037","article-title":"GSK-3 as potential target for therapeutic intervention in cancer","volume":"5","author":"McCubrey","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2017.05.001_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jbior.2014.09.016","article-title":"Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis","volume":"57","author":"McCubrey","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib71","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/j.bbamcr.2016.09.004","article-title":"Effects of mutations in Wnt\/\u03b2-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer","volume":"1863","author":"McCubrey","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbior.2017.05.001_bib72","doi-asserted-by":"crossref","first-page":"14221","DOI":"10.18632\/oncotarget.13991","article-title":"Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells","volume":"8","author":"McCubrey","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2017.05.001_bib73","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/blood-2016-11-696070","article-title":"The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications","volume":"129","author":"Medyouf","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib74","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/bcp.13021","article-title":"AKT in cancer: new molecular insights and advances in drug development","volume":"82","author":"Mundi","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.jbior.2017.05.001_bib75","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/sj.cdd.4401978","article-title":"Unraveling MCL-1 degradation","volume":"13","author":"Opferman","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbior.2017.05.001_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2014-10-604975","article-title":"Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia","volume":"126","author":"Pan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib77","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.aam7622","article-title":"Drugging RAS: know the enemy","volume":"355","author":"Papke","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jbior.2017.05.001_bib78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2008.10.013","article-title":"Glycogen synthase kinase-3 and cancer: good cop, bad cop?","volume":"14","author":"Patel","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.ctdb.2016.11.011","article-title":"Glycogen synthase kinase 3: a kinase for all pathways?","volume":"123","author":"Patel","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.jbior.2017.05.001_bib80","first-page":"17","article-title":"Mesenchymal stem and progenitor cells in normal and dysplastic hematopoiesis-masters of survival and clonality?","author":"Pleyer","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbior.2017.05.001_bib81","first-page":"147","article-title":"Glycogen synthase kinase-3: functions in oncogenesis and development","volume":"1114","author":"Plyte","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbior.2017.05.001_bib82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jbior.2017.05.001_bib83","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2017.05.001_bib84","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/0008-5472.CAN-12-1365","article-title":"Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism","volume":"73","author":"Rahmani","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2017.05.001_bib85","doi-asserted-by":"crossref","first-page":"14736","DOI":"10.1074\/jbc.M910241199","article-title":"Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation","volume":"275","author":"Rimerman","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbior.2017.05.001_bib86","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3109\/10428194.2015.1122781","article-title":"An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia","volume":"57","author":"Rizzieri","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jbior.2017.05.001_bib87","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.272.5264.1023","article-title":"Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly","volume":"272","author":"Rubinfeld","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jbior.2017.05.001_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2017.03.002","article-title":"Cross-talk between the CK2 and AKT signaling pathways in cancer","volume":"64","author":"Ruzzene","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbacli.2015.07.001","article-title":"Phosphorylation of GSK3\u03b1\/\u03b2 correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients","volume":"4","author":"Ruvolo","year":"2015","journal-title":"BBA Clin."},{"key":"10.1016\/j.jbior.2017.05.001_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbacli.2016.08.002","article-title":"The broken \"Off\" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance","volume":"6","author":"Ruvolo","year":"2016","journal-title":"BBA Clin."},{"key":"10.1016\/j.jbior.2017.05.001_bib91","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm979","article-title":"Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor","volume":"10","author":"Sato","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbior.2017.05.001_bib92","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1182\/blood-2004-03-0940","article-title":"RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation","volume":"105","author":"Schwable","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2017.05.001_bib93","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1128\/MCB.05798-11","article-title":"Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage","volume":"31","author":"Seo","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbior.2017.05.001_bib94","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/ijo.2014.2313","article-title":"Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia","volume":"44","author":"Shao","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jbior.2017.05.001_bib95","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-12-800178-3.00002-6","article-title":"\u03b2-Catenin in pluripotency: adhering to self-renewal or Wnting to differentiate?","volume":"312","author":"Sineva","year":"2014","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.jbior.2017.05.001_bib96","series-title":"FLT3 Mutations: Biology and Treatment","first-page":"178","author":"Small","year":"2006"},{"key":"10.1016\/j.jbior.2017.05.001_bib97","doi-asserted-by":"crossref","first-page":"18191","DOI":"10.1074\/jbc.M109708200","article-title":"Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta","volume":"277","author":"Smith","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbior.2017.05.001_bib98","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.exphem.2010.06.001","article-title":"Glycogen synthase kinase\u20133\u03b2 inhibitors suppress leukemia cell growth","volume":"38","author":"Song","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jbior.2017.05.001_bib99","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1074\/jbc.M610906200","article-title":"Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells","volume":"282","author":"Storm","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbior.2017.05.001_bib100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11899-015-0253-6","article-title":"Role of microenvironment in resistance to therapy in AML","volume":"10","author":"Tabe","year":"2015","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.jbior.2017.05.001_bib101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.advenzreg.2011.09.020","article-title":"Achieving specificity in Akt signaling in cancer","volume":"52","author":"Toker","year":"2012","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jbior.2014.04.001","article-title":"Signaling specificity in the Akt pathway in biology and disease","volume":"55","author":"Toker","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2017.05.001_bib103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exphem.2016.12.003","article-title":"Targeting the transcription factor Myb by small-molecule inhibitors","volume":"47","author":"Uttarkar","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jbior.2017.05.001_bib104","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature07284","article-title":"Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy","volume":"455","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2017.05.001_bib105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ccr.2010.04.024","article-title":"GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis","volume":"17","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib106","doi-asserted-by":"crossref","first-page":"29131","DOI":"10.18632\/oncotarget.8675","article-title":"Dual inhibition of AKT\/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2017.05.001_bib107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2005.06.005","article-title":"The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase","volume":"8","author":"Wei","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib108","first-page":"re12","article-title":"Judging a protein by more than its name: GSK-3","volume":"200","author":"Woodgett","year":"2001","journal-title":"Sci. STKE"},{"key":"10.1016\/j.jbior.2017.05.001_bib109","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.4161\/cc.8.24.10111","article-title":"Regulation of protein stability by GSK3 mediated phosphorylation","volume":"8","author":"Xu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2017.05.001_bib110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.febslet.2015.02.021","article-title":"Phosphorylation of Serine422 increases the stability and transactivation activities of human Osterix","volume":"589","author":"Xu","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbior.2017.05.001_bib111","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1242\/jcs.060475","article-title":"GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death","volume":"123","author":"Yang","year":"2010","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jbior.2017.05.001_bib112","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2010.10.032","article-title":"\u03b2-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells","volume":"18","author":"Yeung","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib113","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ncb2283","article-title":"Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal","volume":"13","author":"Yi","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbior.2017.05.001_bib114","doi-asserted-by":"crossref","first-page":"40387","DOI":"10.18632\/oncotarget.9617","article-title":"Integrin alphavbeta3 enhances \u03b2-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity","volume":"7","author":"Yi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2017.05.001_bib115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature06968","article-title":"The ground state of embryonic stem cell self-renewal","volume":"453","author":"Ying","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2017.05.001_bib116","doi-asserted-by":"crossref","first-page":"11740","DOI":"10.1074\/jbc.M413878200","article-title":"Wnt-dependent regulation of the E-cadherin repressor snail","volume":"280","author":"Yook","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbior.2017.05.001_bib117","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ncb1173","article-title":"Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition","volume":"6","author":"Zhou","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbior.2017.05.001_bib118","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1091\/mbc.e11-06-0483","article-title":"GSK3\u03b2 inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb","volume":"22","author":"Zhou","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbior.2017.05.001_bib119","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2741\/3738","article-title":"Myb proteins: angels and demons in normal and transformed cells","volume":"16","author":"Zhou","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.jbior.2017.05.001_bib120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2015.07.001","article-title":"RNA rewriting, recoding, and rewiring in human disease","volume":"21","author":"Zipeto","year":"2015","journal-title":"Trends Mol. Med."}],"container-title":["Advances in Biological Regulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492617300866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492617300866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:23:30Z","timestamp":1761949410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212492617300866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":118,"alternative-id":["S2212492617300866"],"URL":"https:\/\/doi.org\/10.1016\/j.jbior.2017.05.001","relation":{},"ISSN":["2212-4926"],"issn-type":[{"value":"2212-4926","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSK-3 as a novel prognostic indicator in leukemia","name":"articletitle","label":"Article Title"},{"value":"Advances in Biological Regulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbior.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}